The Law Office of Abe Shainberg Announces Investigation of SeraCare Life Sciences, Inc.
NEW YORK--([ BUSINESS WIRE ])--The Law Office of Abe Shainberg is investigating the Board of Directors of SeraCare Life Sciences, Inc. (NASDAQ: SRLS) for possible breaches of fiduciary duty and other violations of state law in connection with the receipt of an unsolicited merger proposal from MSMB Capital. Under the terms of the proposed transaction, SeraCare shareholders would receive $4.25 per share.
For more information, click here: [ http://www.ashainberglaw.com/seracare-life.html ].
The investigation concerns whether the SeraCare Board of Directors is adequately shopping the Company and working to obtain the best price possible for SeraCare shareholders. According to Yahoo! Finance, at least one analyst set a price target for SeraCare stock at $5.00 per share and SeraCare stock traded as high as $4.92 per share as recently as January 11, 2011.
If you own common stock in SeraCare and wish to obtain additional information, please contact Abe Shainberg, Esq. either via email at [ as@ashainberglaw.com ] or by telephone at (212) 425-7286, or visit [ http://www.ashainberglaw.com/seracare-life.html ].
Mr. Shainberg has expertise in prosecuting investor securities litigation, is a certified and registered arbitrator and mediator involving financial matters, and represents investors in various matters nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.